COVID-19: Up to 82% critically ill patients had low Vitamin C values
Tomasa-Irriguible TM, Bielsa-Berrocal L
Nutrition journal · 9 luglio 2021
ABSTRACT DEGLI AUTORI
There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.
Abstract originale, riprodotto senza modifiche. © Gli autori, distribuito con licenza Creative Commons CC BY. Le condizioni esatte sono indicate nel l’articolo originale.
Contenuto di informazione scientifica; non sostituisce il parere di un professionista sanitario. La presenza di uno studio in questa biblioteca non costituisce un’indicazione sui nostri prodotti.
← Tutti gli studi